Conferences
ASCO GU 2018: Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes
February 9, 2018
ASCO GU 2018: Outcomes in Patients with Advanced Prostate Cancer And Inactivating Germline Mutations in BRCA2 or ATM
February 9, 2018
ASCO GU 2018: Incorporating Genomics Into the Management of Systemic Therapy: Advances and Practicality
February 9, 2018
ASCO GU 2018: Impact of Sexual Orientation on Contemporary Rates of Prostate Cancer Screening
February 9, 2018
ASCO GU 2018: Why are Low-risk Prostate Cancers (Pca) Treated Aggressively? A Population-based Cohort Analysis
February 9, 2018
ASCO GU 2018: Statin use and Outcomes of Patients with mCRPC Being Treated with Abiraterone
February 9, 2018
ASCO GU 2018: Can free PSA be used as a biomarker in biochemical recurrence after surgery to predict CRPC?
February 9, 2018
ASCO GU 2018: Radium-223 Retreatment in an International, Open-label, Phase I/II Study in Patients with CRPC and Bone Metastases: 2-year Follow-up
February 9, 2018
ASCO GU 2018: Enzalutamide vs Bicalutamide in Combination with Androgen Deprivation in mHSPC
February 9, 2018
ASCO GU 2018: Overall Survival of Patients with Metastatic Prostate Cancer Starting ADT with Degarelix, A Gonadotropin-releasing Hormone Antagonist
February 9, 2018
ASCO GU 2018: The Clinical Role of Germline and Somatic Genomics and the Risk-Stratification of Localized Prostate Cancer
February 9, 2018